Skip to main content
. Author manuscript; available in PMC: 2020 Nov 15.
Published in final edited form as: Vaccine. 2019 Oct 11;37(48):7155–7164. doi: 10.1016/j.vaccine.2019.09.045

Table 5:

Evidence of reversion of the NS5-K61A/E218A mutant increases after Vero cell passage

Virus P0 P1 P5
K61A < 0.1% < 0.1% < 0.1%
E218A < 0.1% < 0.1% 0.2%
K61A/E218A 3.3% / 2.8% 5.0% / 4.1% 41% / 47%

The frequency of reversion in single nucleotide variants (SNVs) of cell culture stocks of each NS5 mutant are listed. The limit of SNV detection for the LoFreq analysis was 0.1%.

P0, P1, P5 = Vero cell passage 0, 1, or 5